135 related articles for article (PubMed ID: 2509201)
1. Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus. ML-236B (compactin) induces a cytochrome P-450sca in Streptomyces carbophilus that hydroxylates ML-236B to pravastatin sodium (CS-514), a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.
Matsuoka T; Miyakoshi S; Tanzawa K; Nakahara K; Hosobuchi M; Serizawa N
Eur J Biochem; 1989 Oct; 184(3):707-13. PubMed ID: 2509201
[TBL] [Abstract][Full Text] [Related]
2. A two component-type cytochrome P-450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML-236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Serizawa N; Matsuoka T
Biochim Biophys Acta; 1991 Jun; 1084(1):35-40. PubMed ID: 1905157
[TBL] [Abstract][Full Text] [Related]
3. Cloning, characterization and expression of the gene encoding cytochrome P-450sca-2 from Streptomyces carbophilus involved in production of pravastatin, a specific HMG-CoA reductase inhibitor.
Watanabe I; Nara F; Serizawa N
Gene; 1995 Sep; 163(1):81-5. PubMed ID: 7557483
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary X-ray diffraction analysis of cytochrome P450sca-2 from Streptomyces carbophilus involved in production of pravastatin sodium, a tissue-selective inhibitor of HMG-CoA reductase.
Ito S; Matsuoka T; Watanabe I; Kagasaki T; Serizawa N; Hata T
Acta Crystallogr D Biol Crystallogr; 1999 Jun; 55(Pt 6):1209-11. PubMed ID: 10329788
[TBL] [Abstract][Full Text] [Related]
5. Hydroxylation of Compactin (ML-236B) by CYP105D7 (SAV_7469) from
Yao Q; Ma L; Liu L; Ikeda H; Fushinobu S; Li S; Xu LH
J Microbiol Biotechnol; 2017 May; 27(5):956-964. PubMed ID: 28274099
[TBL] [Abstract][Full Text] [Related]
6. Molecular approaches for production of pravastatin, a HMG-CoA reductase inhibitor: transcriptional regulation of the cytochrome p450sca gene from Streptomyces carbophilus by ML-236B sodium salt and phenobarbital.
Watanabe I; Serizawa N
Gene; 1998 Mar; 210(1):109-16. PubMed ID: 9524240
[TBL] [Abstract][Full Text] [Related]
7. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and molecular approaches for production of pravastatin, a potent cholesterol-lowering drug.
Serizawa N
Biotechnol Annu Rev; 1996; 2():373-89. PubMed ID: 9704102
[TBL] [Abstract][Full Text] [Related]
9. Formation of dihydroxy derivative of ML-236B from ML-236B (compactin) by lipid peroxidation.
Serizawa N; Nakahara K; Matsuoka T
J Antibiot (Tokyo); 1990 Aug; 43(8):1031-3. PubMed ID: 2120167
[No Abstract] [Full Text] [Related]
10. [Research and development of pravastatin].
Kishida Y; Naito A; Iwado S; Terahara A; Tsujita Y
Yakugaku Zasshi; 1991 Sep; 111(9):469-87. PubMed ID: 1762049
[TBL] [Abstract][Full Text] [Related]
11. Application of computer to monitoring and control of fermentation process: Microbial conversion of ML-236B Na to pravastatin.
Hosobuchi M; Kurosawa K; Yoshikawa H
Biotechnol Bioeng; 1993 Sep; 42(7):815-20. PubMed ID: 18613128
[TBL] [Abstract][Full Text] [Related]
12. Microbial hydroxylation of compactin (ML-236B) and monacolin K.
Yamashita H; Tsubokawa S; Endo A
J Antibiot (Tokyo); 1985 May; 38(5):605-9. PubMed ID: 4040510
[TBL] [Abstract][Full Text] [Related]
13. Microbial hydroxylation of ML-236B (compactin). Studies on microorganisms capable of 3 beta-hydroxylation of ML-236B.
Serizawa N; Serizawa S; Nakagawa K; Furuya K; Okazaki T; Terahara A
J Antibiot (Tokyo); 1983 Jul; 36(7):887-91. PubMed ID: 6684108
[TBL] [Abstract][Full Text] [Related]
14. 6 alpha-Hydroxy-iso-ML-236B (6 alpha-hydroxy-iso-compactin) and ML-236A, microbial transformation products of ML-236B.
Serizawa N; Nakagawa K; Tsujita Y; Terahara A; Kuwano H; Tanaka M
J Antibiot (Tokyo); 1983 Jul; 36(7):918-20. PubMed ID: 6549610
[No Abstract] [Full Text] [Related]
15. A possible translational control of 3-hydroxy-3-methylglutaryl coenzyme A reductase induction by ML-236b(compactin) in isolated rat hepatocytes.
Koizumi J; Mabuchi H; Takeda R; Okamoto H
Biochem Biophys Res Commun; 1982 Sep; 108(1):240-6. PubMed ID: 7150285
[No Abstract] [Full Text] [Related]
16. Overaccumulation of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase in a compactin(ML-236B)-resistant mouse cell line with defects in the regulation of its activity.
Hasumi K; Yamada A; Shimizu Y; Endo A
Eur J Biochem; 1987 May; 164(3):547-52. PubMed ID: 3569277
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Islam F; Watanabe Y; Hayaishi O
Biochem Int; 1990 Nov; 22(4):601-5. PubMed ID: 2127671
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver.
Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Benet LZ; Sewing KF; Christians U
Drug Metab Dispos; 1999 Feb; 27(2):173-9. PubMed ID: 9929499
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of an ML-236B (compactin) biosynthetic gene cluster in Penicillium citrinum.
Abe Y; Suzuki T; Ono C; Iwamoto K; Hosobuchi M; Yoshikawa H
Mol Genet Genomics; 2002 Jul; 267(5):636-46. PubMed ID: 12172803
[TBL] [Abstract][Full Text] [Related]
20. Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin.
Jacobsen W; Kirchner G; Hallensleben K; Mancinelli L; Deters M; Hackbarth I; Baner K; Benet LZ; Sewing KF; Christians U
J Pharmacol Exp Ther; 1999 Oct; 291(1):131-9. PubMed ID: 10490896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
